Nutrição Ambulatorial

Ponto de vista | Progresso na farmacoterapia para tratamento da obesidade.

24 Jun, 2021 | 10:55h

Progress in Pharmacotherapy for Obesity – JAMA (gratuito por tempo limitado)

Ver também: Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment – JAMA (gratuito por tempo limitado)

Revisão clínica em áudio: Semaglutide for Weight Loss

Mais dados sugerem que não há benefício cardiovascular na suplementação de ômega 3 – Análise secundária do estudo STRENGHT não mostrou associação entre os níveis atingidos de ácido graxo ômega 3 e desfechos cardiovasculares adversos maiores em pacientes com alto risco cardiovascular.

8 Jun, 2021 | 10:20h

Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk: A Secondary Analysis of the STRENGTH Trial – JAMA Cardiology

Estudo original: #AHA20 – Randomized trial: High-dose Omega-3 fatty acids did not reduce the risk of cardiac events in patients at high cardiovascular risk

Comentários: Higher blood levels of omega-3 fatty acids from prescription fish oil showed no effect on CV events – American College of Cardiology

Estudo randomizado: Em pacientes com diabetes tipo 2 tratados com insulina basal e com controle glicêmico ruim (média de HbA1c = 9,1%), o monitoramento contínuo da glicose (MCG) reduziu o nível de HbA1c em 0,4%, em comparação com o cuidado usual (8% e 8,4%). O envolvimento do paciente (i.e., adesão, dieta, atividade física em resposta às leituras do MCG) foi o motivo mais provável de melhora no controle glicêmico.

3 Jun, 2021 | 10:00h

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial – JAMA

Editorial: Broadening Access to Continuous Glucose Monitoring for Patients With Type 2 Diabetes – JAMA

Comentário: Studies support wider CGM access in type 2 diabetes – medwire News

Comentário no Twitter

Continuous glucose monitoring resulted in better glycemic control compared with blood glucose meter monitoring in adults with poorly controlled type 2 diabetes treated with basal insulin without prandial insulin https://t.co/D0y7B8JsJE

— JAMA (@JAMA_current) June 2, 2021

Diretriz USPSTF: Médicos devem propor intervenções de aconselhamento comportamental para promover o ganho de peso saudável e evitar o ganho de peso excessivo durante a gestação.

1 Jun, 2021 | 10:14h

Healthy Weight and Weight Gain In Pregnancy: Behavioral Counseling Interventions – U.S. Preventive Services Task Force

Editorial: Behavioral Counseling Interventions for Healthy Weight During Pregnancy: An Ambitious Endeavor – JAMA

Relatório de evidências: Counseling and Behavioral Interventions for Healthy Weight and Weight Gain in Pregnancy – JAMA

Entrevista com o autor: USPSTF Recommendation: Behavioral Counseling Interventions for Healthy Weight and Weight Gain in Pregnancy – JAMA

Página do paciente JAMA: Behavioral Interventions for Healthy Weight Gain During Pregnancy

Estudo randomizado e controlado de 24 semanas: Em um programa de perda e manutenção de peso, lanches com mistura de sementes oleaginosas resultaram em perda de peso similar e saciedade aumentada em comparação com lanches de carboidratos refinados.

20 Mai, 2021 | 10:47h

Mixed Tree Nut Snacks Compared to Refined Carbohydrate Snacks Resulted in Weight Loss and Increased Satiety during Both Weight Loss and Weight Maintenance: A 24-Week Randomized Controlled Trial – Nutrients

Comentário: Mixed tree nut snacks result in significant weight loss and improved satiety – News Medical

Estudo mostra que limites de IMC para risco de obesidade e diabetes não funcionam em populações não brancas.

12 Mai, 2021 | 09:59h

Study shows BMI cut offs for obesity and diabetes risk do not work for non-white populations – European Association for the Study of Obesity

Estudo original: Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study – The Lancet Diabetes & Endocrinology

M-A: Suplementação de ácidos graxos ômega-3 aumenta o risco de fibrilação atrial em pacientes com dislipidemia.

10 Mai, 2021 | 11:12h

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials – European Heart Journal – Cardiovascular Pharmacotherapy

Comentários: Fish oil supplements linked with heart rhythm disorder – European Society of Cardiology E Could High-Dose Fish Oil Raise Odds for A-Fib in Heart Patients? – HealthDay

Comentário no Twitter

Our latest work showing an increased risk of AFib with O3FA supplementation.

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials https://t.co/7Z8CAuDHNr @totocarbone @gbiondizoccai @MarcoDelBuono3 pic.twitter.com/A5m77y5xTE

— Dave Dixon, PharmD (@DaveDixonPharmD) April 29, 2021

Estudo de coorte: Consumo de bebidas açucaradas entre adultos e adolescentes está relacionado a aumento do risco de câncer colorretal de início precoce em mulheres.

7 Mai, 2021 | 10:21h

Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women – Gut

Comentários: Daily intake of two or more sugar-sweetened drinks associated with higher bowel cancer risk – BMJ E Expert reaction to study looking at sugary drinks intake and incidence of early-onset colorectal cancer among women – Science Media Centre

Estudo randomizado: A combinação de liraglutida + exercícios melhora a manutenção da perda de peso, mais do que cada tratamento isoladamente.

6 Mai, 2021 | 07:30h

Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined – New England Journal of Medicine

Comentário: Liraglutide beneficial for post-diet weight loss maintenance – Medwire News

Diretriz: Diagnóstico e tratamento da disfagia neurogênica.

6 Mai, 2021 | 07:28h

Diagnosis and treatment of neurogenic dysphagia – S1 guideline of the German Society of Neurology – Neurological Research and Practice